Vident Investment Advisory’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-101,213
| Closed | -$500K | – | 1183 |
|
|
2023
Q1 | $500K | Sell |
101,213
-2,913
| -3% | -$14.4K | 0.02% | 780 |
|
|
2022
Q4 | $655K | Buy |
104,126
+38,995
| +60% | +$245K | 0.02% | 622 |
|
|
2022
Q3 | $702K | Sell |
65,131
-6,885
| -10% | -$74.2K | 0.02% | 686 |
|
|
2022
Q2 | $821K | Sell |
72,016
-5,441
| -7% | -$62K | 0.02% | 691 |
|
|
2022
Q1 | $706K | Buy |
77,457
+12,910
| +20% | +$118K | 0.02% | 817 |
|
|
2021
Q4 | $963K | Buy |
64,547
+7,968
| +14% | +$119K | 0.03% | 720 |
|
|
2021
Q3 | $1.45M | Sell |
56,579
-4,042
| -7% | -$104K | 0.04% | 556 |
|
|
2021
Q2 | $1.58M | Buy |
60,621
+1,057
| +2% | +$27.6K | 0.05% | 499 |
|
|
2021
Q1 | $2.1M | Hold |
59,564
| – | – | 0.07% | 354 |
|
|
2020
Q4 | $1.5M | Buy |
59,564
+29,228
| +96% | +$738K | 0.06% | 403 |
|
|
2020
Q3 | $1.14M | Sell |
30,336
-6,070
| -17% | -$229K | 0.06% | 452 |
|
|
2020
Q2 | $1.56M | Sell |
36,406
-18,342
| -34% | -$785K | 0.08% | 296 |
|
|
2020
Q1 | $1.06M | Sell |
54,748
-1,322
| -2% | -$25.7K | 0.07% | 373 |
|
|
2019
Q4 | $1.46M | Buy |
56,070
+3,247
| +6% | +$84.4K | 0.09% | 338 |
|
|
2019
Q3 | $1.44M | Sell |
52,823
-1,509
| -3% | -$41.1K | 0.13% | 119 |
|
|
2019
Q2 | $1.46M | Sell |
54,332
-4,998
| -8% | -$134K | 0.12% | 122 |
|
|
2019
Q1 | $1.72M | Sell |
59,330
-1,352
| -2% | -$39.1K | 0.09% | 314 |
|
|
2018
Q4 | $1.63M | Buy |
+60,682
| New | +$1.63M | 0.09% | 300 |
|